Search Within

Department of Medicine

Formats
  1. Journal Article (19575)
  2. Meeting Abstract (16038)
  3. Review (1147)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (235)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22311)
  2. Hematologic Malignancies, Division of (13266)
  3. Center for Hematologic Malignancies (11051)
  4. GSK Faculty (10641)
  5. Survivorship Research (9324)
  6. Division of Subspecialty Medicine (7532)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1068)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1046)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3721)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6456)
  2. Elsevier Inc. (4214)
  3. American Society of Hematology (4000)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2109)

More Publishers

Results (39597)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Docetaxel as part of first-line chemotherapy for gastric cancer
    Editorial

    Kelsen, D.
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes of transarterial hepatic embolization versus yttrium-90 radioembolization for treatment of patients with hepatocellular carcinoma >7 cm
    Journal Article

    Son, S. Y.; Velayati, S.; Zhao, K.; Marinelli, B.; Geevarghese, R.; Sotirchos, V. S.; Covey, A.; Harding, J. J.; D'Angelica, M. I.; Jarnagin, W. R.; more...
    Journal of Vascular and Interventional Radiology (2025)

    Fulltext@MSK | Save
  • Gene copy deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic features and association with the outcomes of immunotherapy with or without chemotherapy in nonsquamous NSCLC
    Journal Article

    Gandhi, M. M.; Elkrief, A.; Moore, C. G.; Ricciuti, B.; Alessi, J. V.; Richards, A. L.; Tischfield, S.; Williams, J.; Lamberti, G.; Pecci, F.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Esophagectomy may have a role in stage IV esophageal adenocarcinoma
    Journal Article

    Sewell, M.; Toumbacaris, N.; Tan, K. S.; Bahadur, N.; Philip, J.; Shah, N. J.; Niederhausern, A.; Tavarez Martinez, C.; Zheng, H.; Boerner, T.; more...
    Journal of Thoracic and Cardiovascular Surgery (2025)

    Fulltext@MSK | Save
  • Oral and topical Janus kinase inhibitors in patients with cutaneous t-cell lymphoma: A real-world single-center experience
    Journal Article

    Liao, V.; Lavin, L.; Ong, M. M.; Pulitzer, M. P.; Moskowitz, A. J.; Myskowski, P. L.; Geller, S.
    Journal of Dermatology (2025)

    Fulltext@MSK | Save
  • Implementation of universal germline genetic testing into standard of care for patients with prostate cancer: The time is now
    Journal Article

    Shore, N.; Nielsen, S. M.; Esplin, E. D.; Antonarakis, E. S.; Barata, P. C.; Beer, T. M.; Beltran, H.; Bryce, A.; Cookson, M. S.; Crawford, E. D.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Management of EGFR-variant and ALK-positive non-small cell lung cancer brain metastasis
    Editorial

    Pike, L. R. G.; Yu, H.; Rusthoven, C. G.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • A plain language summary of the molecular changes in the tumors of people with BRAF V600E–mutant colorectal cancer in the BEACON study
    Editorial

    Kopetz, S.; Murphy, D. A.; Pu, J.; Ciardiello, F.; Desai, J.; Van Cutsem, E.; Wasan, H. S.; Yoshino, T.; Saffari, H.; Zhang, X.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • The potential benefit of encorafenib plus cetuximab with chemotherapy compared with standard of care in people with BRAF V600E-mutant metastatic colorectal cancer in the BREAKWATER study: A plain language summary
    Editorial

    Kopetz, S.; Yoshino, T.; Van Cutsem, E.; Eng, C.; Kim, T. W.; Wasan, H. S.; Desai, J.; Ciardiello, F.; Yaeger, R.; Maughan, T. S.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • A first-in-human phase I study of LOXO-338, an oral selective Bcl-2 inhibitor, in patients with advanced hematologic malignancies
    Journal Article

    Kwiatek, M.; Murthy, G. S. G.; Hoffmann, M.; Tessoulin, B.; Danilov, A.; Alencar, A. J.; Shah, N. N.; Ghesquieres, H.; Le Gouill, S.; Jurczak, W.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save